Fig. 3
From: Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
A combined analysis of urinary proteomics and tissue IHC. (A) Diagnostic power of a urinary proteomic model including 31 peptide markers for HCC, illustrated by ROC. (B) Tissue IHC confirmed the dysregulation of KLK6 and MEP1A, two proteases potentially involved in HCC progression, deduced by the N- and C-terminals of 31 differential peptides. (A–B) Reprinted from Bannaga et al., 2017